<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2022-3-73-80</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-4909</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Влияние возраста, высокоуглеводной и высокожировой диеты на развитие артериальной гипертензии и поражения почек в эксперименте</article-title><trans-title-group xml:lang="en"><trans-title>The effect of age and a high-fat, high-carbohydrate diet on the development of arterial hypertension and kidney disease in the experiment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3526-7875</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мустафина</surname><given-names>Л. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Mustafina</surname><given-names>L. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мустафина Лилия Рамильевна – доктор медицинских наук, доцент, профессор кафедры гистологии, эмбриологии и цитологии, СибГМУ.</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">lrmustafina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9876-6957</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логвинов</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Logvinov</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Логвинов Сергей Валентинович – доктор медицинских наук, профессор, заведующий кафедрой гистологии, эмбриологии и цитологии, СибГМУ.</p><p>634050, Томск, Московский тракт, 2</p></bio><bio xml:lang="en"><p>2, Moscow Trakt, Tomsk, 634050</p></bio><email xlink:type="simple">s_logvinov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2264-1928</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нарыжная</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Naryzhnaya</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нарыжная Наталья Владимировна – доктор медицинских наук, ведущий научный сотрудник, лаборатория экспериментальной кардиологии, НИИ кардиологии, Томский НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>111а, Kievskaya Str., Tomsk, 634012</p></bio><email xlink:type="simple">natalynar@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9603-822X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курбатов</surname><given-names>Б. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurbatov</surname><given-names>B. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курбатов Борис Константинович – младший научный сотрудник, лаборатория экспериментальной кардиологии, НИИ кардиологии, Томский НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>111а, Kievskaya Str., Tomsk, 634012</p></bio><email xlink:type="simple">bobersanker@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6020-1598</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маслов</surname><given-names>Л. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maslov</surname><given-names>L. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маслов Леонид Николаевич – доктор медицинских наук, профессор, руководитель лаборатории экспериментальной кардиологии, НИИ кардиологии, Томский НИМЦ.</p><p>634012, Томск, ул. Киевская, 111а</p></bio><bio xml:lang="en"><p>111а, Kievskaya Str., Tomsk, 634012</p></bio><email xlink:type="simple">maslov@cardio-tomsk.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет (СибГМУ)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Научно-исследовательский институт (НИИ) кардиологии, Томский национальный исследовательский медицинский центр (НИМЦ), Российская академия наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Cardiology Research Institute, Tomsk National Research Medical Center (NRMC), Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>14</day><month>10</month><year>2022</year></pub-date><volume>21</volume><issue>3</issue><fpage>73</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мустафина Л.Р., Логвинов С.В., Нарыжная Н.В., Курбатов Б.К., Маслов Л.Н., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Мустафина Л.Р., Логвинов С.В., Нарыжная Н.В., Курбатов Б.К., Маслов Л.Н.</copyright-holder><copyright-holder xml:lang="en">Mustafina L.R., Logvinov S.V., Naryzhnaya N.V., Kurbatov B.K., Maslov L.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/4909">https://bulletin.ssmu.ru/jour/article/view/4909</self-uri><abstract><sec><title>Цель</title><p>Цель: выявить структурные основы патогенеза артериальной гипертензии и поражения почек, связанных с высокоуглеводной высокожировой диетой (ВУСЖД) и возрастом у крыс линии Wistar.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Исследование проводили на самцах крыс линии Wistar в возрасте 60 и 450 сут. Животных распределяли на четыре группы: 1-я (n = 14) – интактные крысы (возраст 60 сут), содержащиеся на стандартном рационе в течение 90 сут; 2-я (n = 14) – крысы (возраст 60 сут), содержащиеся на ВУВЖД в течение 90 сут; 3-я (n = 14) – интактные крысы (возраст 450 сут), содержащиеся на стандартном рационе в течение 90 сут; 4-я (n = 14) – крысы (возраст 450 сут), содержащиеся на ВУВЖД в течение 90 сут. Использовались клинико-инструментальный, иммуноферментный, иммуногистохимический и гистологический методы исследования.</p></sec><sec><title>Результаты</title><p>Результаты. Высокоуглеводная высокожировая диета приводила у 60-дневных животных к увеличению массы тела и абдоминального жира, нарастанию систолического артериального давления, появлению умеренно выраженных гистологических изменений почек. У интактных 450-дневных крыс преобладали изменения, связанные с возрастом: увеличение массы миокарда, увеличение TGF-β1 в сыворотке крови, морфологические изменения почечных канальцев и клубочков. У 450-дневных крыс, содержащихся на ВУВЖД, отмечалось наиболее выраженное нарастание как систолического, так и диастолического артериального давления, значительное увеличение концентрации фибронектина в сыворотке крови, выраженные деструктивные изменения в почечной паренхиме.</p></sec><sec><title>Заключение</title><p>Заключение. Функциональные и биохимические признаки артериальной гипертензии и морфологические изменения в почках были наиболее выражены у 450-дневных крыс, содержавшихся на ВУВЖД.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To identify the structural foundations of the pathogenesis of arterial hypertension and kidney disease associated with a high-fat, high-carbohydrate diet and age.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study was carried out on male Wistar rats aged 60 and 450 days. The animals were divided into 4 groups: group 1 (n = 14) – intact rats (60 days old) fed with a standard diet for 90 days; group 2 (n = 14) – rats (aged 60 days) receiving a high-fat, high-carbohydrate diet for 90 days; group 3 (n = 14) – intact rats (aged 450 days) receiving a standard diet for 90 days; group 4 (n = 14) – rats (aged 450 days) fed with a high-fat, high-carbohydrate diet for 90 days. Clinical and instrumental research methods, enzyme-linked immunosorbent assay, and immunohistochemistry and histology techniques were used in the study.</p></sec><sec><title>Results</title><p>Results. Feeding 60-day-old animals with a high-fat, high-carbohydrate diet resulted in an increase in body weight and abdominal fat, a rise in systolic blood pressure, and moderately pronounced histologic changes in the kidneys. In intact 450-day-old rats, age-related changes prevailed: changes in the myocardial mass, an increase in TGF-β1, morphological changes in the renal tubules and glomeruli. In 450-day-old rats receiving a high-fat, highcarbohydrate diet, the most pronounced increase in both systolic and diastolic blood pressure, a significant rise in serum fibronectin, and destructive changes in the renal tissue were noted.</p></sec><sec><title>Conclusion</title><p>Conclusion. Functional and biochemical signs of arterial hypertension and morphological changes in the kidneys were the most pronounced in 450-day-old rats fed with a high-fat, high-carbohydrate diet.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертензия</kwd><kwd>возрастные изменения почек</kwd><kwd>высокоуглеводная высокожировая диета</kwd></kwd-group><kwd-group xml:lang="en"><kwd>arterial hypertension</kwd><kwd>age-related changes in the kidneys</kwd><kwd>high-fat</kwd><kwd>high-carbohydrate diet</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы выражают благодарность А.В. Мухомедзянову, А.С. Горбунову, Н.С. Воронкову за помощь в проведении эксперимента, В.В. Иванову, Ю.Г. Бирулиной – за методическую помощь при разработке диеты</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Beslay M., Srour B., Méjean C., Allès B., Fiolet T., Debras C. et al. Ultra-processed food intake in association with BMI change and risk of overweight and obesity: A prospective analysis of the French NutriNet-Santé cohort. PLoS Med. 2020;17(8):e1003256. DOI: 10.1371/journal.pmed.1003256.</mixed-citation><mixed-citation xml:lang="en">Beslay M., Srour B., Méjean C., Allès B., Fiolet T., Debras C. et al. Ultra-processed food intake in association with BMI change and risk of overweight and obesity: A prospective analysis of the French NutriNet-Santé cohort. PLoS Med. 2020;17(8):e1003256. DOI: 10.1371/journal.pmed.1003256.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Katsimardou A., Imprialos K., Stavropoulos K., Sachinidis A., Doumas M., Athyros V. Hypertension in metabolic syndrome: novel insights. Curr. Hypertens. Rev. 2020;16(1):12–18. DOI: 10.2174/1573402115666190415161813.</mixed-citation><mixed-citation xml:lang="en">Katsimardou A., Imprialos K., Stavropoulos K., Sachinidis A., Doumas M., Athyros V. Hypertension in metabolic syndrome: novel insights. Curr. Hypertens. Rev. 2020;16(1):12–18. DOI: 10.2174/1573402115666190415161813.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H.H., Lee D.K., Liu M., Portincasa P., Wang D.Q. Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatr. Gastroenterol. Hepatol. Nutr. 2020;23(3):189–230. DOI: 10.5223/pghn.2020.23.3.189.</mixed-citation><mixed-citation xml:lang="en">Wang H.H., Lee D.K., Liu M., Portincasa P., Wang D.Q. Novel insights into the pathogenesis and management of the metabolic syndrome. Pediatr. Gastroenterol. Hepatol. Nutr. 2020;23(3):189–230. DOI: 10.5223/pghn.2020.23.3.189.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gouveia É.R., Gouveia B.R., Marques A., Peralta M., França C., Lima A. et al. Predictors of metabolic syndrome in adults and older adults from Amazonas, Brazil. Int. J. Environ. Res. Public. Health. 2021;18(3):1303. DOI: 10.3390/ijerph18031303.</mixed-citation><mixed-citation xml:lang="en">Gouveia É.R., Gouveia B.R., Marques A., Peralta M., França C., Lima A. et al. Predictors of metabolic syndrome in adults and older adults from Amazonas, Brazil. Int. J. Environ. Res. Public. Health. 2021;18(3):1303. DOI: 10.3390/ijerph18031303.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">La Russa D., Giordano F., Marrone A., Parafati M., Janda E., Pellegrino D. Oxidative imbalance and kidney damage in cafeteria diet-induced rat model of metabolic syndrome: effect of bergamot polyphenolic fraction. Antioxidants (Basel). 2019;8(3):66. DOI: 10.3390/antiox8030066.</mixed-citation><mixed-citation xml:lang="en">La Russa D., Giordano F., Marrone A., Parafati M., Janda E., Pellegrino D. Oxidative imbalance and kidney damage in cafeteria diet-induced rat model of metabolic syndrome: effect of bergamot polyphenolic fraction. Antioxidants (Basel). 2019;8(3):66. DOI: 10.3390/antiox8030066.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kiuchi M.G., Mion D.Jr. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope? Kidney Res. Clin. Pract. 2016;35(1):3–9. DOI: 10.1016/j.krcp.2015.11.003.</mixed-citation><mixed-citation xml:lang="en">Kiuchi M.G., Mion D.Jr. Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope? Kidney Res. Clin. Pract. 2016;35(1):3–9. DOI: 10.1016/j.krcp.2015.11.003.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Бирулина Ю.Г., Иванов В.В., Буйко Е.Е., Быков В.В., Смаглий Л.В., Носарев А.В. и др. Экспериментальная модель метаболического синдрома у крыс на основе высокожировой и высокоуглеводной диеты. Бюллетень сибирской медицины. 2020;19(4):14–20. DOI: 10.20538/1682-0363-20204-14-20.</mixed-citation><mixed-citation xml:lang="en">Бирулина Ю.Г., Иванов В.В., Буйко Е.Е., Быков В.В., Смаглий Л.В., Носарев А.В. и др. Экспериментальная модель метаболического синдрома у крыс на основе высокожировой и высокоуглеводной диеты. Бюллетень сибирской медицины. 2020;19(4):14–20. DOI: 10.20538/1682-0363-20204-14-20.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bonfim T.H.F.D., Tavares R.L., de Vasconcelos M.H.A., Gouveia M., Nunes P.C., Soares N.L. et al. Potentially obesogenic diets alter metabolic and neurobehavioural parameters in Wistar rats: a comparison between two dietary models. J. Affect. Disord. 2021;279:451–461. DOI: 10.1016/j.jad.2020.10.034.</mixed-citation><mixed-citation xml:lang="en">Bonfim T.H.F.D., Tavares R.L., de Vasconcelos M.H.A., Gouveia M., Nunes P.C., Soares N.L. et al. Potentially obesogenic diets alter metabolic and neurobehavioural parameters in Wistar rats: a comparison between two dietary models. J. Affect. Disord. 2021;279:451–461. DOI: 10.1016/j.jad.2020.10.034.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kizhner T., Werman M.J. Long-term fructose intake: biochemical consequences and altered renal histology in the male rat. Metabolism. 2002;51(12):1538–1547. DOI: 10.1053/ meta.2002.36306.</mixed-citation><mixed-citation xml:lang="en">Kizhner T., Werman M.J. Long-term fructose intake: biochemical consequences and altered renal histology in the male rat. Metabolism. 2002;51(12):1538–1547. DOI: 10.1053/ meta.2002.36306.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Komnenov D., Levanovich P.E., Rossi N.F. Hypertension associated with fructose and high salt: renal and sympathetic mechanisms. Nutrients. 2019;11(3):569. DOI: 10.3390/nu11030569.</mixed-citation><mixed-citation xml:lang="en">Komnenov D., Levanovich P.E., Rossi N.F. Hypertension associated with fructose and high salt: renal and sympathetic mechanisms. Nutrients. 2019;11(3):569. DOI: 10.3390/nu11030569.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Madero M., Perez-Pozo S.E., Jalal D., Johnson R.J., Sánchez-Lozada L.G. Dietary fructose and hypertension. Curr. Hypertens. Rep. 2011;13(1):29–35. DOI: 10.1007/s11906010-0163-x.</mixed-citation><mixed-citation xml:lang="en">Madero M., Perez-Pozo S.E., Jalal D., Johnson R.J., Sánchez-Lozada L.G. Dietary fructose and hypertension. Curr. Hypertens. Rep. 2011;13(1):29–35. DOI: 10.1007/s11906010-0163-x.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hurcombe J.A., Hartley P., Lay A.C., Ni L., Bedford J.J., Leader J.P. et al. Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function. Nat. Commun. 2019;10(1):403. DOI: 10.1038/s41467-018-08235-1.</mixed-citation><mixed-citation xml:lang="en">Hurcombe J.A., Hartley P., Lay A.C., Ni L., Bedford J.J., Leader J.P. et al. Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function. Nat. Commun. 2019;10(1):403. DOI: 10.1038/s41467-018-08235-1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kolset S.O., Reinholt F.P., Jenssen T. Diabetic nephropathy and extracellular matrix. J. Histochem. Cytochem. 2012;60:976–986. DOI: 10.1369/0022155412465073.</mixed-citation><mixed-citation xml:lang="en">Kolset S.O., Reinholt F.P., Jenssen T. Diabetic nephropathy and extracellular matrix. J. Histochem. Cytochem. 2012;60:976–986. DOI: 10.1369/0022155412465073.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kim D., Li H.Y., Lee J.H., Oh Y.S., Jun H.S. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling. Exp. Mol. Med. 2019;51(2):1–10. DOI: 10.1038/s12276-019-0217-3.</mixed-citation><mixed-citation xml:lang="en">Kim D., Li H.Y., Lee J.H., Oh Y.S., Jun H.S. Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1/MAPK/KLF5 signaling. Exp. Mol. Med. 2019;51(2):1–10. DOI: 10.1038/s12276-019-0217-3.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hou S., Zhang T., Li Y., Guo F., Jin X. Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK/ SIRT1/PGC-1α signaling in db/db mice. J. Diabetes. Res. 2017;2017:2865912. DOI: 10.1155/2017/2865912.</mixed-citation><mixed-citation xml:lang="en">Hou S., Zhang T., Li Y., Guo F., Jin X. Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK/ SIRT1/PGC-1α signaling in db/db mice. J. Diabetes. Res. 2017;2017:2865912. DOI: 10.1155/2017/2865912.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rao R.P., Jain A., Srinivasan B. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats. J. Renin Angiotensin Aldosterone Syst. 2011;12(3):169–175. DOI: 10.1177/1470320310392097.</mixed-citation><mixed-citation xml:lang="en">Rao R.P., Jain A., Srinivasan B. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats. J. Renin Angiotensin Aldosterone Syst. 2011;12(3):169–175. DOI: 10.1177/1470320310392097.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Huang F., Guo Y., Wang L., Jing L., Chen Z., Lu S. et al. High glucose and TGF-β1 reduce expression of endoplasmic reticulum-resident selenoprotein S and selenoprotein N in human mesangial cells. Ren. Fail. 2019;41(1):762–769. DOI: 10.1080/0886022X.2019.1641413.</mixed-citation><mixed-citation xml:lang="en">Huang F., Guo Y., Wang L., Jing L., Chen Z., Lu S. et al. High glucose and TGF-β1 reduce expression of endoplasmic reticulum-resident selenoprotein S and selenoprotein N in human mesangial cells. Ren. Fail. 2019;41(1):762–769. DOI: 10.1080/0886022X.2019.1641413.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Hara M., Kusaba T., Ono K., Masuzawa N., Nakamura I., Urata N. et al. Extraglomerular vascular involvement of glomerulopathy with fibronectin deposits. Intern. Med. 2021; 60(13):2103–2107. DOI: 10.2169/internalmedicine.6558-20.</mixed-citation><mixed-citation xml:lang="en">Hara M., Kusaba T., Ono K., Masuzawa N., Nakamura I., Urata N. et al. Extraglomerular vascular involvement of glomerulopathy with fibronectin deposits. Intern. Med. 2021; 60(13):2103–2107. DOI: 10.2169/internalmedicine.6558-20.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Klemis V., Ghura H., Federico G., Würfel C., Bentmann A., Gretz N. et al. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney Int. 2017;91(6):1374–1385. DOI: 10.1016/j.kint.2016.12.006.</mixed-citation><mixed-citation xml:lang="en">Klemis V., Ghura H., Federico G., Würfel C., Bentmann A., Gretz N. et al. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes. Kidney Int. 2017;91(6):1374–1385. DOI: 10.1016/j.kint.2016.12.006.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Molvarec A., Szarka A., Walentin S., Szucs E., Nagy B., Rigó J.Jr. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens. Res. 2010;33(9):892–898. DOI: 10.1038/hr.2010.92.</mixed-citation><mixed-citation xml:lang="en">Molvarec A., Szarka A., Walentin S., Szucs E., Nagy B., Rigó J.Jr. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens. Res. 2010;33(9):892–898. DOI: 10.1038/hr.2010.92.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Song K.S., Kim H.K., Shim W., Jee S.H. Plasma fibronec tin levels in ischemic heart disease. Atherosclerosis. 2001;154(2):449–453. DOI: 10.1016/s0021-9150(00)00490-1.</mixed-citation><mixed-citation xml:lang="en">Song K.S., Kim H.K., Shim W., Jee S.H. Plasma fibronec tin levels in ischemic heart disease. Atherosclerosis. 2001;154(2):449–453. DOI: 10.1016/s0021-9150(00)00490-1.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
